The rapid influx of foreign private equity into India's healthcare sector has fundamentally transformed ownership patterns across hospitals, cancer care networks, fertility clinics and medical device companies. According to The Hindu BusinessLine, global investors now hold significant stakes across some of India's largest healthcare providers, with several moving beyond minority financial investments to controlling ownership. The trend extends beyond hospitals to include fertility chains such as Indira IVF, Nova IVF and Oasis Fertility, cancer care providers, medical device manufacturers and healthcare technology companies.
The growing presence of financial investors across the healthcare ecosystem reflects what Dr Indranil, Professor at the School of Government and Public Policy at OP Jindal Global University, describes as the increasing 'corporatisation and financialisation' of healthcare. As reported by The Hindu BusinessLine, the key distinction between community-based healthcare providers and corporate hospital chains lies in their financial structure. While independent practitioners and smaller nursing homes are largely driven by medical considerations and local community relationships, large corporate hospitals increasingly operate under pressure to generate returns for investors.
According to Dr Indranil's analysis, once revenue growth becomes a central objective, hospitals face incentives to maximise billable procedures and high-value interventions. As reported by The Hindu BusinessLine, this can potentially influence treatment choices, reduce doctors' professional autonomy and increase healthcare costs for patients. His recent study highlighted another emerging concern: the growing share of corporate hospitals owned by investors based outside India, making regulatory oversight more difficult and placing shareholder interests at the centre of decision-making.
Dr Prachinkumar Ghodajkar from JNU warned that global experience suggests healthcare should remain the state's responsibility as a public good. According to The Hindu BusinessLine, he cited the US healthcare system, where much is run by the corporate sector through insurance, noting that one of the leading causes of death is iatrogenesis — deaths resulting from medical interventions. Professor Mathew George of Central University of Kerala reported that patients are already experiencing catastrophic financial consequences, with treatment costs rising sharply and a ₹5-lakh insurance cover now often exhausted in a single hospitalisation.
